Project Details
Description
OPTIMIZE: A Phase II Study of Reduced Dose Post Transplantation Cyclophosphamide as GvHD Prophylaxis in Adult Patients with Hematologic Malignancies Receiving HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
| Status | Active |
|---|---|
| Effective start/end date | 1/23/24 → 1/22/34 |
Funding
- NATIONAL MARROW DONOR PROGRAM
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.